TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.
Perspective Therapeutics Reports Second Quarter Fiscal 2023 Results and Recent Business Highlights businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updates streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Raymond James analyst Rahul Sarugaser maintained an “Outperform” rating on Fusion Pharmaceuticals in a Tuesday client report, saying the company is breaking new ground in cancer research.